Novel therapeutic and diagnostic antibodies against KIR3DL2, a unique tumor antigen overexpressed on subtypes of T cell lymphomas - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Journal for Immunotherapy of Cancer Year : 2013

Novel therapeutic and diagnostic antibodies against KIR3DL2, a unique tumor antigen overexpressed on subtypes of T cell lymphomas

Domains

Cancer
Fichier principal
Vignette du fichier
2051-1426-1-S1-P45.pdf (175.7 Ko) Télécharger le fichier
2051-1426-1-S1-P45.xml (4.43 Ko) Télécharger le fichier
Origin Publisher files allowed on an open archive
Format Other

Dates and versions

inserm-00881037 , version 1 (07-11-2013)

Identifiers

  • HAL Id : inserm-00881037 , version 1

Cite

Anne Marie-Cardine, Nicolas Viaud, Arnaud Dujardin, Joly Rachel, Nathalie Granier, et al.. Novel therapeutic and diagnostic antibodies against KIR3DL2, a unique tumor antigen overexpressed on subtypes of T cell lymphomas. Journal for Immunotherapy of Cancer, 2013, 1 (Suppl 1), pp.P45. ⟨inserm-00881037⟩
317 View
278 Download

Share

Gmail Mastodon Facebook X LinkedIn More